title: Heterozygous Familial Hypercholesterolemia.
authors.affiliation: From The Ohio State University College of Medicine (A.O.), Division of Human Genetics (A.C.S.), and Dorothy M. Davis Heart and Lung Research Institute (A.C.S.), Ohio State University Wexner Medical Center.
authors.forename: Angela
authors.initials: A
authors.lastname: Onorato
authors.affiliation: From The Ohio State University College of Medicine (A.O.), Division of Human Genetics (A.C.S.), and Dorothy M. Davis Heart and Lung Research Institute (A.C.S.), Ohio State University Wexner Medical Center. Amy.Sturm@osumc.edu.
authors.forename: Amy C
authors.initials: AC
authors.lastname: Sturm
mesh_terms: D000328:Adult; D017668:Age of Onset; D050197:Atherosclerosis / Q000209:etiology / Q000517:prevention & control; D002648:Child; D002675:Child, Preschool; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control; D005192:Family Health; D005260:Female; D005817:Genetic Counseling; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006579:Heterozygote; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors